Juvenile Myelomonocytic Leukemia

Authors

  • Amna Imtiaz Department of Pathology, Pakistan Institute of Medical Sciences, Islamabad
  • Lubna Naseem Department of Pathology, Pakistan Institute of Medical Sciences, Islamabad
  • Sundas Ali Department of Pathology, Pakistan Institute of Medical Sciences, Islamabad

Keywords:

Juvenile Myelomonocytic Leukaemia, Hematopoietic Stem Cell Transplantation

Abstract

Juvenile Myelomonocytic Leukemia (JMML), which comes under the WHO category of Myelodysplastic/
Myeloproliferative Neoplasms, is a rare aggressive hematological malignancy of early childhood caused by
excessive proliferation of cells of monocytic and granulocytic lineages. The peripheral blood shows leukocytosis,
thrombocytopenia and anemia. The majority of patients present with infection. Hematopoietic Stem Cell
Transplantation (HSCT) is the best treatment option available. Here we present a case of a one year old female
child who presented with complaints of fever, cough and progressive pallor for the last six months and
abdominal distention associated with vomiting, diarrhea and sub-conjunctival hemorrhages for past 2 months.
The fever did not respond to medication. She developed sepsis and intracranial bleed and expired on the 10th day
of hospitalization

Downloads

Published

2018-11-21

Issue

Section

Original article

How to Cite

1.
Imtiaz A, Naseem L, Ali S. Juvenile Myelomonocytic Leukemia. Int J Pathol [Internet]. 2018 Nov. 21 [cited 2024 Nov. 22];:129-32. Available from: https://jpathology.com/index.php/OJS/article/view/253

Most read articles by the same author(s)

<< < 1 2